Skip to main content
OpenTrials
Completed

NCT Number: NCT04377321

Colchicine Has Anti-diabetic Effect

Colchicine has antidiabetic effect and may be an option for type 2 diabetes management

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Treatment Adherence Behavior Diabetes Mellitus Diabetes Mellitus, Type 2 Endocrine System Diseases Glucose Metabolism Disorders Health Behavior Metabolic Diseases Nutritional and Metabolic Diseases Treatment Adherence and Compliance

Age range

35 year–55 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Mahmoud Younis

Cairo, 11865, Egypt

About this study

Observational cohort prospective study with following of 150 newly diagnosed type 2 diabetes patients who were in 3 groups, had been monitored in a private clinic, each group 50 patients number, with 30 females and 20 males after written consent from all patients. The ages of all patients were between 35 and 55 years.

The aim of this study was to evaluate colchicine effect on A1C of newly diagnosed type2 diabetes compared to the metformin and control group on diet only.

The first group patients received colchicine 0.5twice daily for 6 months, the second group received metformin 1gm twice daily, the third group patients were on diet only. During the period of treatment, the investigators followed the patients if there were side effects of the drugs used. No side effects were monitored during the period of treatment except for gastric upset in some patients using metformin

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • type 2 diabetes newly diagnosed age 35- 55 years

Exclusion criteria

  • severe anemia hypothyroidism and hyperthyroidism moderate to severe liver or kidney disease

Treatment and study plan

Colchicine Tablets

Drug

colchicine tabletes for 6 months

Primary outcomes

  1. colchicine for treatment of type diabetes patients

    Time frame: 6 months

    colchicine tablets .5 mg twice daily for 6 months

Sponsors and collaborators

Lead sponsor

Ministry of Health and Population, Egypt

Other Gov

Registry information

Official study title

Colchicine Has Anti-diabetic Effect and May be an Option for Type 2 Diabetes Management

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
May 6, 2020
Registry last updated
May 6, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.